Effective Cancer Recurrence Prediction using Healthcare Data Analytics with Machine Learning and Artificial Intelligence

Empowered with health data, artificial intelligence (AI) and data analytics demonstrate transformative potential in cancer recurrence prediction and treatment. This paper explores the potential of AI in predicting cancer recurrence incidences, enabling earlier interventions, and potentially improving patient outcomes. Currently, limitations such as late diagnosis or misdiagnosis often result in suboptimal patient outcomes and increased healthcare costs, emphasizing a crucial requirement for an efficient prediction system in the initial stage of Cancer. AI, particularly machine learning (ML) and deep learning (DL), coupled with health data analytics, provides a promising platform for developing predictive models in cancer care. Harnessing patients' demographic, genetic, clinical, and lifestyle data, these intelligent models can identify risk factors and patterns associated with various types of Cancer. These insights assist healthcare providers in predicting susceptibility to specific cancer types in the early stages when intervention can significantly improve prognosis. Additionally, AI's ability to continually learn allows the models to become more accurate, adapting to new findings and trends in cancer care. Implementing AI in healthcare for cancer prediction also enables personalized medicine, ensuring that each patient's unique genetic makeup and lifestyle factors are considered in determining treatment plans. This paper delves into the comprehensive role of data analytics and AI in reshaping cancer care, acting as invaluable tools in predictive oncology.